|
0022
|
-
|
Phase I/II Study of Conformal and Intensity Modulated Irradiation for Oropharyngeal Cancer
- CLOSED
|
|
0116
|
-
|
A Two-part Phase I/II Study of Extended field External Irradiation and Intracavitary Brachytherapy Combined with Chemotherapy (weekly Cisplatin-arm 1) and Amifostine (weekly Cisplatin and Amifostine-arm 2) in Carcinoma of the Cervix with Positive Para-aortic or High Common Iliac lymph Nodes - CLOSED
|
|
0117
|
-
|
A Phase I/II Dose Intensification Study using Three
Dimensional Conformal Radiation Therapy and Concurrent Chemotherapy for
Patients with Inoperable, non-small Cell Lung Cancer.- CLOSED
|
|
0126
|
-
|
A Phase III Randomized Study of High Dose 3D-CRT/IMRT versus Standard Dose 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer - CLOSED
|
|
0225
|
-
|
A Phase II Study of Intensity Modulated Radiation Therapy (IMRT) +/- Chemotherapy for Nasopharyngeal Cancer
- CLOSED
|
|
0232
|
-
|
A Phase III Study Comparing Combined External Beam Radiation and Transperineal Interstitial Permanent Brachytherapy with Brachytherapy alone for Selected Patients with Intermediate Risk Prostatic Carcinoma -- CLOSED
|
|
0234
|
-
|
A Phase II Randomized Trial of Surgery Followed by Chemoradiotherapy plus C225 (Cetuximab) for Advanced Squamous Cell Carcinoma of the Head and Neck - CLOSED
|
|
0236
|
-
|
A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Medically Inoperable Stage I/II Non-Small Cell Lung Cancer. --CLOSED
|
|
0321
|
-
|
Phase II Trial of Combined High Dose Rate Brachytherapy and External Beam Radiotherapy for Adenocarcinoma of the Prostate --CLOSED
|
|
0413
|
-
|
A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) versus Partial Breast Irradiation (PBI) for Women with State 0,I, or II Breast Cancer
---CLOSED
(4/16/2013)
|
|
0415
|
-
|
A Phase III Randomized Study of Hypofractionated 3D-CRT/IMRT Versus Conventionally Fractionated 3D-CRT/IMRT in Patients with Favorable-risk Prostate Cancer --CLOSED
|
|
0417
|
-
|
A Phase II Study of Bevacizumab in Combination with Definitive Radiotherapy and Cisplatin Chemotherapy in Untreated Patients with Locally Advanced Cervical Carcinoma --CLOSED
|
|
0418
|
-
|
A Phase II Study of Intensity Modulated Radiation Therapy (IMRT) to the Pelvis +/- Chemotherapy for Post-operative Patients with either Endometrial or Cervical Carcinoma --CLOSED
|
|
0421
|
-
|
A Phase III Trial for Locally Recurrent, Previously
Irradiated Head and Neck Cancer: Concurrent Re-irradiation and
Chemotherapy versus Chemotherapy alone.---CLOSED
|
|
0435
|
-
|
A Randomized, Phase III,Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Palifermin for the Reduction of Oral Mucositis in Patients with Locally Advanced Head and Neck Cancer Receiving Radiation Therapy with Concurrent Chemotherapy. --CLOSED
|
|
0438
|
-
|
A Phase I Trial of Highly Conformal Radiation Therapy for
Patients with Liver Metastases. --CLOSED
|
|
0521
|
-
|
A Phase III Protocol of Androgen Suppression (AS) and
3DCRT/IMRT vs AS and 3DCRT/IMRT Followed by Chemotherapy With Docetaxel and
Prednisone for Localized, High-Risk Prostate Cancer.---CLOSED
(8/21/2009)
|
|
0522
|
-
|
A Phase III Trial of Concurrent Accelerated Radiation and
Cisplatin versus Concurrent Accelerated Radiation, Cisplatin, and Cetuximab
(C225)[Followed by Surgery for Selected Patients] for Stage III and IV Head and
Neck Carcinomas. --CLOSED
|
|
0526
|
-
|
A Prospective Phase II Trial of Transperineal Ultrasound-guided Brachytherapy for Locally Recurrent Prostate Adenocarcinoma Following External Beam Radiotherapy ---CLOSED
(1/21/2014)
|
|
0529
|
-
|
A Phase II Evaluation of Dose-Painted IMRT in Combination with 5-Fluorouracil and Mitomycin-C for Reduction of Acute Morbidity in Carcinoma of the Anal
Canal---CLOSED
|
|
0534
|
-
|
A Phase III Trial Of Short Term Androgen Deprivation With Pelvic Lymph Node Or Prostate Bed Only Radiotherapy (SPPORT) In Prostate Cancer Patients With A Rising PSA After Radical Prostatectomy ---Closed(3/30/2015)
|
|
0539
|
-
|
Phase II Trial of Observation For Low-Risk Meningiomas and of Radiotherapy for Intermediate - and High-Risk Meningiomas---CLOSED
|
|
0615
|
-
|
A Phase II Study of Concurrent Chemoradiotherapy Using Three-Dimensional Conformal Radiotherapy (3D-CRT) or Intensity-Modulated Radiation Therapy (IMRT) + Bevacizumab (BV) for Locally or Regionally Advanced Nasopharyngeal Cancer ---Closed(2/5/2009)
|
|
0617
|
-
|
A Randomized Phase III Comparison of Standard-dose (60 Gy) versus High-dose (74 Gy) Conformal Radiotherapy with Concurrent and Consolidation Carboplatin/paclitaxel in Patients with Stage IIIA/IIIB Non-small Cell Lung Cancer---CLOSED(11/22/2011)
|
|
0618
|
-
|
A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Operable Stage I/II Non-Small Cell Lung Cancer --CLOSED(5/17/2010)
|
|
0619
|
-
|
A Randomized Phase II Trial of Chemoradiotherapy Versus Chmoradiotherapy and Vandetanib For High-Risk Postoperative Advanced Squamous Cell Carcinoma of the Head and Neck. --CLOSED(5/3/2010)
|
|
0621
|
-
|
Adjuvant 3DCRT/IMRT in Combination with Androgen Suppression and Docetaxel for High Risk Prostate Cancer Patients
Post-Prostatectomy: a Phase II trial - CLOSED
|
|
0622
|
-
|
A Phase II Trial of Samarium 153 Followed by Salvage Prostatic FOSSA 3DCRT or IMRT Irradiation in High-rick, Clinically Non-metastatic Prostate Cancer After Radical Prostatectomy--CLOSED(2/28/2014)
|
|
0623
|
-
|
A Phase II trial of combined modality therapy with growth factor support for patients with limited stage small cell lung cancer. --CLOSED(4/6/2009)
|
|
0630
|
-
|
A Phase II Trial of Image Guided Preoperative Radiotherapy for Primary Soft Tissue Sarcomas of the Extremities. --CLOSED(9/23/2010)
|
|
0631
|
-
|
Phase II/III Study of Image-Guided Radiosurgery/SBRT for Localized Spine Metastasis--CLOSED(8/4/2017)
|
|
0813
|
-
|
Seamless Phase I/II Study Of Stereotactic Lung Radiotherapy (SBRT) For Early Stage, Centrally Located, Non-Small Cell Lung Cancer (NSCLC) In Medically Inoperable Patients--CLOSED(9/5/2013)
|
|
0815
|
-
|
A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy With or Without Short-Term Androgen Deprivation Therapy For Patients With Intermediate-Risk Prostate Cancer--CLOSED(3/9/2016)
|
|
0822
|
-
|
A Phase II Evaluation of Preoperative Chemoradiotherapy utilizing Intensity Modulated Radiation Therapy (IMRT) in combination with Capecitabine and Oxaliplatin for patients with locally Advanced Rectal Cancer - CLOSED
|
|
0825
|
-
|
Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma - CLOSED (5/11/2011)
|
|
0831
|
-
|
A Randomized, Double-Blinded, Placebo-Controlled Phase III Trial to Evaluate the Effectiveness of a Phosphodiesterase 5 Inhibitor,
Tadalafil, in Prevention of Erectile Dysfunction in Patients Treated with Radiotherapy for Prostate Cancer - CLOSED(2/16/2012)
|
|
0837
|
-
|
Randomized, Phase II, Double-Blind, Placebo-Controlled Trial of Conventional Chemoradiation And Adjuvant
Temozolomide Plus Cediranib Versus Conventional Chemoradiation And Adjuvant Temozolomide Plus
Placebo In Patients With Newly Diagnosed Glioblastoma ---CLOSED
(5/9/2012)
|
|
0839
|
-
|
Randomized Phase II Study of Pre-operative Chemoradiotherapy +/- Panitumumab (IND #110152)
Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced
(Stage IIIA, N2+) Non-Small Cell Lung Cancer---CLOSED
(1/13/2017)
|
|
0912
|
-
|
A Randomized Phase II Study of Concurrent Intensity Modulated Radiation Therapy (IMRT),
Paclitaxel, and Pazopanib (NSC 737754)/Placebo for the Treatment of Anaplastic Thyroid Cancer---CLOSED
(1/1/2017)
|
|
0913
|
-
|
Phase I/II trial of Concurrent RAD001 (Everolimus) with Temozolomide/Radiation Followed By Adjuvant RAD001/Temozolomide In Newly Diagnosed Glioblastoma -- CLOSED(9/4/2013)
|
|
0915
|
-
|
A Randomized Phase II Study Comparing 2 Stereotactic Body Radiation Therapy (SBRT) Schedules For Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer ---CLOSED
(3/22/2011)
|
| 0920
|
-
|
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab For Locally-Advanced Resected Head And Neck Cancer
- CLOSED (03/27/2018)
|
|
0921
|
-
|
A Phase II Study of Postoperative Intensity Modulated Radiation Therapy (IMRT) With Concurrent Cisplatin and Bevacizumab Followed By Carboplatin and Paclitaxel For Patients with Endometrial Cancer ---CLOSED
(12/12/2011)
|
| 0924 |
- |
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Closed on 06/24/2019
|
| 0926
|
-
|
A Phase II Protocol for Patients with Stage T1 Bladder Cancer to Evaluate Selective Bladder Preserving Treatment by Radiation Therapy Concurrent with Radiosensitizing Chemotherapy Following a Thorough Transurethral Surgical Re-Staging
--- CLOSED (12/20/2017)
|
|
0933
|
-
|
A Phase II Trial of Hippocampal Avoidance During Whole Brain Radiotherapy for Brain Metastases ---Closed
(11/7/2012)
|
|
0937
|
-
|
Randomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone To Prophylactic Cranial Irradiation And
Consolidative Extra-Cranial Irradiation For Extensive Disease Small Cell Lung Cancer (ED-SCLC)---CLOSED
(3/2/2015)
|
|
0938
|
-
|
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer--CLOSED(2/10/2014)
|
| 1005 |
- |
A Phase III Trial of Accelerated Whole Breast Irradiation with Hypofractionation plus Concurrent Boost
versus Standard Whole Breast Irradiation Plus Sequential Boost for Early-Stage Breast Cancer --CLOSED(5/20/2014)
|
|
1010
|
-
|
A Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of HER2-
Overexpressing Esophageal Adenocarcinoma ---
CLOSED
(1.12.2016)
|
|
1012
|
-
|
Phase II Randomized Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy Induced Esophagitis-Related Pain During the Treatment of Lung Cancer--CLOSED
(10/15/2013)
|
|
1014
|
-
|
A Phase II Study of Repeat Breast Preserving Surgery and 3D-Conformal Partial Breast Re-Irradiation (PBrI) for Local Recurrence of Breast Carcinoma ---CLOSED
|
| 1016 |
- |
Phase III Trial of Radiotherapy Plus Cetuximab versus Chemoradiotherapy
in HPV-Associated Oropharynx Cancer --Closed(8/16/2017)
|
|
1021
|
-
|
A Randomized Phase III Study of Sublobar Resection (+/- Brachytherapy) versus Stereotactic Body Radiation Therapy in High Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC)---CLOSED(5/15/2013)
|
|
1106
|
-
|
Randomized Phase II Trial of Individualized Adaptive Radiotherapy Using During-Treatment FDG-PET/CT
and Modern Technology in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)---CLOSED(3/6/2017)
|
|
1115
|
-
|
Phase III Trial of Dose Escalated Radiation Therapy and Standard Androgen Deprivation Therapy (ADT) with A Gnrh Agonist vs. Dose Escalated Radiation Therapy and Enhanced ADT with a Gnrh Agonist and TAK-700 For Men with High Risk Prostate Cancer. ---CLOSED
(10.1.2014)
|
|
1119
|
-
|
Phase II Randomized Study of Whole Brain Radiotherapy/Stereotactic Radiosurgery in Combination with Concurrent Lapatinib in Patients with Brain Metastasis From Her2-Positive Breast Cancer - A Collaborative study of NRG Oncology and KROG
Closed(9/12/19 )
|
|
1174
|
-
|
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: THE OUTBACK TRIAL---CLOSED
(6/1/2017)
|
|
1201
|
-
|
A Phase II Randomized Trial of High Versus Standard Intensity Local or Systemic Therapy for Unresectable Pancreatic Cance--CLOSED
(8/16/2017)
|
|
1203
|
-
|
A Randomized Phase III Study of Standard vs. IMRT Pelvic Radiation For Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C) --CLOSED
(8/16/2017)
|
|
1205
|
-
|
Randomized Phase II Trial of Concurrent Bevacizumab and Re-Irradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma.---CLOSED
(5.10.2016)
|
|
1221
|
-
|
Randomized Phase II Trial of Transoral Endoscopic Head And Neck Surgery followed by Risk-Based IMRT and Weekly Cisplatin versus IMRT and Weekly Cisplatin for HPV Negative Oropharynx Cancer---CLOSED
(2.26.2015)
|
| 1306
|
-
|
A Randomized Phase II Study of Individualized Combined Modality Therapy for Stage III Non-Small Cell Lung Cancer (NSCLC) ---- CLOSED (12/20/2017)
|
|
0848
|
-
|
A Phase III Trial Evaluating Both Erlotinib And Chemoradiation as Adjuvant Treament For Patients With Resected Head of Pancreas Adenocarcinoma---Closed(January 18,2019)
|
|
1270
|
-
|
NCCTG N107C/Endorsed Study: A Phase III Trial of Post-Surgical Stereotactic Radiosurgery (SRS) Compared With Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease-----Closed at 12/18/2015
|
|
1304
|
-
|
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in patients with Positive Axillary Nodes before Neoadjuvant Chemotherapy who convert to Pathologically Negative Axillary Nodes after Neoadjuvant Chemotherapy-Closed
at 12/28/2020
|
|
0538
|
-
|
Phase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide
-Closed at 12/01/2019
|
|
1008
|
-
|
A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy
Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
(closed
on 3/8/2021)
|
|
1112
|
-
|
Randomized Phase III Study of Sorafenib Versus Stereotactic Body Radiation Therapy Followed by Sorafenib in Hepatocellular Carcinoma(closed on March 10th,2021)
|